Coagulase-negative staphylococci (CoNS) are among the most frequently recovered
bacteria in routine clinical care. Their incidence has steadily increased over the past …

Objectives Antibiotic treatment for bone and joint infections generally lasts for 6 weeks or
longer. Linezolid may be a good option for treating bone and joint infections, but there is an …

Staphylococcus aureus is an important cause of various infections in humans, including
bacteremia, skin and soft tissue infections, and infections associated with implanted medical …

Orthopedic infections are challenging pathologies that impose a heavy burden on patients
and the healthcare system. Antimicrobial therapy is a critical component of the successful …

Objectives Dalbavancin is a lipoglycopeptide antibiotic approved for the treatment of acute
bacterial skin and skin structure infections. However, several studies have suggested that it …

Antibiotic resistance is a growing global concern, but our understanding of the spread of
resistant bacteria in remote regions remains limited. While some level of intrinsic resistance …

Abstract Background Bone infections from Staphylococcus aureus are notoriously difficult to
treat and have high recurrence rates. Local antibiotic delivery systems hold the potential to …

Rifampicin is one of the mainstays in treating staphylococcal prosthetic joint infection (PJI).
However, discontinuation due to intolerance, drug interactions, and adverse events is …

The Bacillus and Paenibacillus genera are diverse soil-related bacterial pathogens. In this
case report, we describe, to our knowledge, the first report of septic arthritis in a native hip …

Background: Increasing antibiotic resistance has been reported as an issue in the systemic
treatment of periprosthetic joint infection (PJI). Linezolid offers the advantages of high oral …